Glycolysis upregulation is neuroprotective as a compensatory mechanism in ALS.

Manzo, Ernesto; Lorenzini, Ileana; Barrameda, Dianne; O'Conner, Abigail G; Barrows, Jordan M; Starr, Alexander; Kovalik, Tina; Rabichow, Benjamin E et al. · Elife · 2019

basic_science · Level V

Where this comes from

Abstract

Amyotrophic Lateral Sclerosis (ALS), is a fatal neurodegenerative disorder, with TDP-43 inclusions as a major pathological hallmark. Using a <i>Drosophila</i> model of TDP-43 proteinopathy we found significant alterations in glucose metabolism including increased pyruvate, suggesting that modulating glycolysis may be neuroprotective. Indeed, a high sugar diet improves locomotor and lifespan defects caused by TDP-43 proteinopathy in motor neurons or glia, but not muscle, suggesting that metabolic dysregulation occurs in the nervous system. Overexpressing human glucose transporter GLUT-3 in motor neurons mitigates TDP-43 dependent defects in synaptic vesicle recycling and improves locomotion. Furthermore, <i>PFK</i> mRNA, a key indicator of glycolysis, is upregulated in flies and patient derived iPSC motor neurons with TDP-43 pathology. Surprisingly, <i>PFK</i> overexpression rescues TDP-43 induced locomotor deficits. These findings from multiple ALS models show that mechanistically, glycolysis is upregulated in degenerating motor neurons as a compensatory mechanism and suggest that increased glucose availability is protective.

Medical subject headings